Show simple item record

dc.contributor.authorShamash, Jen_US
dc.contributor.authorPowles, Ten_US
dc.contributor.authorSarker, SJen_US
dc.contributor.authorProtheroe, Aen_US
dc.contributor.authorMithal, Nen_US
dc.contributor.authorMills, Ren_US
dc.contributor.authorBeard, Ren_US
dc.contributor.authorWilson, Pen_US
dc.contributor.authorTranter, Nen_US
dc.contributor.authorO'Brien, Nen_US
dc.contributor.authorMcFaul, Sen_US
dc.contributor.authorOliver, Ten_US
dc.date.accessioned2016-01-06T13:10:39Z
dc.date.issued2011-02-15en_US
dc.date.submitted2016-01-05T18:39:11.053Z
dc.identifier.issn0007-0920en_US
dc.identifier.other10.1038/bjc.2011.7
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/10335
dc.descriptionFrom twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License.en_US
dc.description.sponsorshipLondon NHS Trust sponsored this studyen_US
dc.format.extent620 - 628en_US
dc.language.isoenen_US
dc.relation.ispartofBRIT J CANCERen_US
dc.subjectCRPCen_US
dc.subjectDexamethasoneen_US
dc.subjectDiethylstilbestrolen_US
dc.subjecttreatment sequencingen_US
dc.subjectMITOXANTRONE PLUS PREDNISONEen_US
dc.subjectABIRATERONE ACETATEen_US
dc.subjectANDROGEN RECEPTORen_US
dc.subjectCLINICAL-TRIALSen_US
dc.subjectWORKING GROUPen_US
dc.subjectCELL-GROWTHen_US
dc.subjectEND-POINTSen_US
dc.subjectRECOMMENDATIONSen_US
dc.subjectCHEMOTHERAPYen_US
dc.subjectDOCETAXELen_US
dc.titleA multi-centre randomised phase III trial of Dexamethasone vs Dexamethasone and diethylstilbestrol in castration-resistant prostate cancer: immediate vs deferred Diethylstilbestrolen_US
dc.typeArticle
dc.rights.holder2011. Cancer Research UK
dc.identifier.doi10.1038/sj.bjc.6606102en_US
pubs.issue4en_US
pubs.notesNot knownen_US
pubs.volume104en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record